ANDA 62911, held by Hospira. Vancomycin Hydrochloride.
As of Nov 16, 2026, ANDA 62911 (Vancomycin Hydrochloride), held by Hospira, was first approved by FDA on Aug 4, 1988, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 4, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vancomycin HydrochlorideEQ 500MG BASE/VIAL · injectable;injection | Vancomycin Hydrochloride | Rx |
| May 24, 2021 | Supplement 61Labeling · Standard review | Approved | None posted |
| Sep 1, 2020 | Supplement 55Labeling · Standard review | Approved | None posted |
| Sep 1, 2020 | Supplement 47Labeling · Standard review | Approved | None posted |
| Sep 1, 2020 | Supplement 43Labeling · Standard review | Approved | None posted |
| Apr 13, 2017 | Supplement 45Labeling · Standard review | Approved | None posted |
| May 8, 2012 | Supplement 42Labeling | Approved | None posted |
| Nov 30, 2011 | Supplement 35Labeling | Approved | |
| Nov 18, 2008 | Supplement 32Labeling | Approved | None posted |
| Aug 21, 2008 | Supplement 16Labeling | Approved | None posted |
| Oct 4, 2002 | Supplement 12Manufacturing | Approved | None posted |
| Feb 1, 2002 | Supplement 11Manufacturing | Approved | None posted |
| Jun 14, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Jul 14, 2000 | Supplement 9Manufacturing | Approved | None posted |
| Dec 9, 1998 | Supplement 8Manufacturing | Approved | None posted |
| Nov 13, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Oct 22, 1993 | Supplement 5Manufacturing | Approved | None posted |
| Jul 23, 1991 | Supplement 3Manufacturing | Approved | None posted |
| Dec 5, 1988 | Supplement 2Manufacturing | Approved | None posted |
| Dec 5, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Aug 4, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters